Back to search

Sweden· SE-20150711000036

Kargluminsyra Waymade 200 mg Dispergerbar tablett

A medicinal product containing carglumic acid, registered in Sweden by Waymade BV.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedKargluminsyra Waymade 200 mg Disperge…ATC—REGISTER NO.SE-20150711000036PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Carglumic Acid
Manufacturer
Waymade BV
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20150711000036

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Carglumic acid in 17 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All carglumic acid products

Authorised across Europe · EMA

The same active substance is authorised in 16 EEA countries. Names it is sold under:

  • Austria · Carglumsäure Waymade
  • Czechia · Carglumic Acid
  • Germany · Carglumsäure Waymade, Carglumsäure Zentiva
  • Denmark · Cargluminsyre
  • Spain · Ácido Carglúmico, Ácido Carglúmico Tillomed
  • Finland · Karglumiinihappo Waymade
  • France · Acide Carglumique Tillomed, Acide Carglumique Waymade
  • United Kingdom (Northern Ireland) · Carglumic Acid Waymade
  • Greece · Carglumic Acid, Carglumic Acid Tillomed
  • Iceland · Carbaglu, Ucedane
  • Italy · Acido Carglumico Waymade
  • Liechtenstein · Carbaglu, Ucedane
  • Netherlands · Carglumaatzuur Tillomed, Carglumaatzuur Waymade
  • Norway · Carbaglu, Kargluminsyre Waymade
  • Poland · Kwas Kargluminowy
  • Portugal · Ácido Carglúmico, Ácido Carglúmico Waymade

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/08920e58-d2f2-4ffd-bd75-9be78ad1518c
GET /v1/drugs/08920e58-d2f2-4ffd-bd75-9be78ad1518c?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "SmPC",
    "PL",
    "sPAR",
    "PAR",
    "sRMP"
  ],
  "se_npl_id": "20150711000036",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20150711000036",
  "product_doc_link": "https://docetp.mpa.se/LMF/Kargluminsyra%20Waymade%2C%20dispersible%20tablet%20ENG%20SmPC_09001bee809f2fa1.pdf"
}

See everything about carglumic acid.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.